TD Ameritrade Investment Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-395
| Closed | -$37K | – | 153 |
|
|
2023
Q2 | $37K | Buy |
395
+384
| +3,491% | +$36K | ﹤0.01% | 260 |
|
|
2023
Q1 | $1K | Hold |
11
| – | – | ﹤0.01% | 544 |
|
|
2022
Q4 | $1K | Sell |
11
-35
| -76% | -$3.18K | ﹤0.01% | 544 |
|
|
2022
Q3 | $4K | Sell |
46
-31
| -40% | -$2.7K | ﹤0.01% | 440 |
|
|
2022
Q2 | $7K | Sell |
77
-5
| -6% | -$455 | ﹤0.01% | 448 |
|
|
2022
Q1 | $10K | Buy |
82
+4
| +5% | +$488 | ﹤0.01% | 500 |
|
|
2021
Q4 | $10K | Buy |
78
+55
| +239% | +$7.05K | ﹤0.01% | 485 |
|
|
2021
Q3 | $2K | Sell |
23
-20
| -47% | -$1.74K | ﹤0.01% | 579 |
|
|
2021
Q2 | $4K | Buy |
43
+23
| +115% | +$2.14K | ﹤0.01% | 542 |
|
|
2021
Q1 | $2K | Hold |
20
| – | – | ﹤0.01% | 583 |
|
|
2020
Q4 | $2K | Sell |
20
-3
| -13% | -$300 | ﹤0.01% | 583 |
|
|
2020
Q3 | $2K | Hold |
23
| – | – | ﹤0.01% | 579 |
|
|
2020
Q2 | $2K | Sell |
23
-4
| -15% | -$348 | ﹤0.01% | 568 |
|
|
2020
Q1 | $2K | Sell |
27
-3
| -10% | -$222 | ﹤0.01% | 541 |
|
|
2019
Q4 | $2K | Buy |
30
+27
| +900% | +$1.8K | ﹤0.01% | 569 |
|
|
2019
Q3 | $0 | Buy |
+3
| New | – | ﹤0.01% | 652 |
|
|
2019
Q2 | – | Sell |
-465
| Closed | -$30K | – | 651 |
|
|
2019
Q1 | $30K | Buy |
+465
| New | +$30K | ﹤0.01% | 285 |
|